Deutsche Bank
SGMO

Deutsche Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Deutsche Bank’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-62,549
Closed -$41.9K – 3684
2024
Q1 		$41.9K Sell
62,549
-95,571
-60% -$69.3K ﹤0.01% 3428
2023
Q4 		$85.4K Buy
158,120
+95,792
+154% +$44.2K ﹤0.01% 3291
2023
Q3 		$37.4K Hold
62,328
– – ﹤0.01% 3459
2023
Q2 		$81K Sell
62,328
-51,045
-45% -$69.7K ﹤0.01% 3355
2023
Q1 		$200K Buy
113,373
+30,157
+36% +$86.1K ﹤0.01% 3009
2022
Q4 		$261K Buy
83,216
+29,671
+55% +$115K ﹤0.01% 2808
2022
Q3 		$262K Sell
53,545
-11,141
-17% -$57.2K ﹤0.01% 2778
2022
Q2 		$267K Sell
64,686
-11,856
-15% -$51.3K ﹤0.01% 2996
2022
Q1 		$445K Sell
76,542
-7,318
-9% -$43.5K ﹤0.01% 2817
2021
Q4 		$629K Buy
83,860
+3,972
+5% +$34.5K ﹤0.01% 2694
2021
Q3 		$719K Sell
79,888
-5,910
-7% -$58.4K ﹤0.01% 2820
2021
Q2 		$1.03M Sell
85,798
-2,217
-3% -$25.1K ﹤0.01% 2750
2021
Q1 		$1.1M Sell
88,015
-173,449
-66% -$2.34M ﹤0.01% 2601
2020
Q4 		$4.08M Buy
261,464
+57,287
+28% +$671K ﹤0.01% 1465
2020
Q3 		$1.93M Sell
204,177
-247,078
-55% -$2.67M ﹤0.01% 1765
2020
Q2 		$4.04M Buy
451,255
+339,409
+303% +$3.15M ﹤0.01% 1411
2020
Q1 		$713K Sell
111,846
-551,650
-83% -$4.09M ﹤0.01% 2285
2019
Q4 		$5.55M Sell
663,496
-239,286
-27% -$2.2M ﹤0.01% 1386
2019
Q3 		$8.17M Sell
902,782
-554,190
-38% -$6.22M 0.01% 1170
2019
Q2 		$15.7M Buy
1,456,972
+481,525
+49% +$5.12M 0.01% 1086
2019
Q1 		$9.3M Buy
975,447
+787,569
+419% +$8.04M 0.01% 1423
2018
Q4 		$2.15M Sell
187,878
-728,952
-80% -$9.06M ﹤0.01% 2345
2018
Q3 		$15.5M Buy
916,830
+139,899
+18% +$2.13M 0.01% 1298
2018
Q2 		$11M Buy
776,931
+279,704
+56% +$4.65M 0.01% 1658
2018
Q1 		$9.45M Buy
497,227
+259,876
+109% +$5.56M ﹤0.01% 1664
2017
Q4 		$3.89M Sell
237,351
-782,985
-77% -$11.6M ﹤0.01% 2215
2017
Q3 		$15.3M Buy
1,020,336
+878,540
+620% +$9.71M 0.01% 1193
2017
Q2 		$1.25M Sell
141,796
-248,185
-64% -$1.59M ﹤0.01% 2867
2017
Q1 		$2.03M Sell
389,981
-278,195
-42% -$1.12M ﹤0.01% 2235
2016
Q4 		$2.04M Sell
668,176
-128,649
-16% -$468K ﹤0.01% 2249
2016
Q3 		$3.69M Buy
796,825
+295,926
+59% +$1.51M ﹤0.01% 1946
2016
Q2 		$2.9M Sell
500,899
-135,809
-21% -$866K ﹤0.01% 2130
2016
Q1 		$3.85M Buy
636,708
+160,267
+34% +$962K ﹤0.01% 1927
2015
Q4 		$4.35M Sell
476,441
-642,954
-57% -$4.95M ﹤0.01% 1890
2015
Q3 		$6.31M Buy
1,119,395
+440,133
+65% +$3.63M ﹤0.01% 1624
2015
Q2 		$7.53M Buy
679,262
+98,541
+17% +$1.27M ﹤0.01% 1525
2015
Q1 		$9.1M Buy
580,721
+475,695
+453% +$7.36M 0.01% 1405
2014
Q4 		$1.59M Sell
105,026
-136,183
-56% -$1.65M ﹤0.01% 2848
2014
Q3 		$2.6M Buy
241,209
+103,184
+75% +$1.35M ﹤0.01% 2320
2014
Q2 		$2.1M Buy
138,025
+28,622
+26% +$412K ﹤0.01% 2420
2014
Q1 		$1.98M Sell
109,403
-114,955
-51% -$2.22M ﹤0.01% 2410
2013
Q4 		$3.11M Sell
224,358
-56,573
-20% -$651K ﹤0.01% 2040
2013
Q3 		$2.94M Buy
280,931
+51,888
+23% +$515K ﹤0.01% 2211
2013
Q2 		$1.79M Buy
+229,043
New +$2M ﹤0.01% 2301

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank's SGMO Position: Q2 2024 in Review

Deutsche Bank sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 62,549 shares — an estimated $41.9K sold.

Deutsche Bank first reported a position in SGMO in Q2 2013 and held it in 44 quarters. The position peaked at $15.7M in Q2 2019. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.

  • Deutsche Bank reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 62,549 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $41.9K.
  • Deutsche Bank first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 44 quarters.
  • Deutsche Bank's SANGAMO THERAPEUTICS INC position peaked at $15.7M in Q2 2019.
  • 129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.